113 related articles for article (PubMed ID: 24225844)
1. Discontinuous foci of cancer in a single core of prostatic biopsy: when it occurs and performance of quantification methods in a private-practice setting.
Schultz L; Maluf CE; da Silva RC; Falashi Rde H; da Costa MV; Schultz MI
Am J Surg Pathol; 2013 Dec; 37(12):1831-6. PubMed ID: 24225844
[TBL] [Abstract][Full Text] [Related]
2. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
Karram S; Trock BJ; Netto GJ; Epstein JI
Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
Epstein JI
J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
[TBL] [Abstract][Full Text] [Related]
4. Standardization of reporting discontinuous tumor involvement in prostatic needle biopsy: a systematic review.
Lu M; Wu S; Wu CL
Virchows Arch; 2021 Mar; 478(3):383-391. PubMed ID: 33404850
[TBL] [Abstract][Full Text] [Related]
5. Does discontinuous involvement of a prostatic needle biopsy core by adenocarcinoma correlate with a large tumor focus at radical prostatectomy?
Arias-Stella JA; Varma KR; Montoya-Cerrillo D; Gupta NS; Williamson SR
Am J Surg Pathol; 2015 Feb; 39(2):281-6. PubMed ID: 25353288
[TBL] [Abstract][Full Text] [Related]
6. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
[TBL] [Abstract][Full Text] [Related]
7. Continuous versus discontinuous tumor involvement: A dilemma in prostate biopsy quantitation.
Bsirini C; Danakas AM; Miyamoto H
Prostate; 2018 Nov; 78(15):1166-1171. PubMed ID: 29992589
[TBL] [Abstract][Full Text] [Related]
8. The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishes organ-confined from advanced prostate cancer at radical prostatectomy.
Kuniyasu H; Ukai R; Johnston D; Troncoso P; Fidler IJ; Pettaway CA
Clin Cancer Res; 2003 Jun; 9(6):2185-94. PubMed ID: 12796385
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
10. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K
Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061
[TBL] [Abstract][Full Text] [Related]
11. Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy.
Brimo F; Xu B; Scarlata E; Bégin LR; Spatz A; Salomon L; Zakaria AS; Ploussard G; Bladou F; Kassouf W; Tanguay S; Chevalier S; Ye H; Aprikian A
Hum Pathol; 2014 Oct; 45(10):2006-13. PubMed ID: 25152453
[TBL] [Abstract][Full Text] [Related]
12. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
13. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
14. Detection of cancer in radical prostatectomy specimens with no residual carcinoma in the initial review of slides.
Duffield AS; Epstein JI
Am J Surg Pathol; 2009 Jan; 33(1):120-5. PubMed ID: 18971774
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart.
Ko J; Falzarano SM; Walker E; Streator Smith K; Stephenson AJ; Klein EA; Magi-Galluzzi C
Prostate; 2013 Jun; 73(8):897-903. PubMed ID: 23280623
[TBL] [Abstract][Full Text] [Related]
16. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
Poulos CK; Daggy JK; Cheng L
Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathologic study of preoperative and postoperative findings with minute Gleason 3+3=6 cancer at radical prostatectomy.
Osunkoya AO; Carter HB; Epstein JI
Urology; 2008 Sep; 72(3):638-40. PubMed ID: 18400278
[TBL] [Abstract][Full Text] [Related]
18. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]